Treatment with the PKCδ inhibitor significantly attenuated the thrombocytopenia (P < 0.05, CLP plus vehicle vs CLP + PKCδ inhibitor) and circulating platelet levels were similar to blood levels measured in sham surgery animals (P = NS sham vs CLP + PKCδ inhibitor). The gene discussed is PRKCD; the disease is Thrombocytopenia.